Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 361-380 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 361 | Romanian InSpace Engineering lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only provides older membership context that Romanian InSpace Engineering was part of the consortium that developed the EMISAR satellite via article; that is insufficient for a current positive thesis within this ranking window. Why now: No why-now catalyst is evidenced because there are no retained 90-day evidence. Caveats: Reviewed evidence references but provides no. Single historical membership-support mention only. No retained evidence after recent evidence window. |
| 362 | Safran lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not provide direct positive company-specific evidence within the available 90-day evidence set. Only older or contextual references are cited in the membership rationale, including thematic propulsion or battery market reports and a reference to expanded small-satellite propulsion manufacturing, but no direct post-recent evidence window evidence is available for scoring. Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 270 article IDs considered but 0 article IDs after recent evidence window and 0 evidence available after dedupe, so recency-based thesis formation is not supported. Caveats: Membership rationale references article IDs 2026-04, and, but no are provided in the reviewed sources, so they cannot be cited as factual scoring evidence under the the evidence standard. Evidence recent evidence review shows 0 kept rows after the 90-day cutoff. |
| 363 | SatLeo Labs lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence rationale says SatLeo Labs raised seed funding for a multispectral and thermal Earth observation constellation, but no retained article/evidence are available here to support a stronger opportunity ranking. Why now: No retained within the recent evidence window evidence are provided, so there is no reviewed sources-supported why-now beyond cohort inclusion rationale. Caveats: Only membership rationale is available; no citeable retained evidence. Small-company universe but zero available evidence after recent evidence window. |
| 364 | SciTec lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources say AI software came from a SciTec subsidiary in connection with Firefly's lunar imaging service, but this is only supporting article context without retained direct evidence, so it does not support a strong long-horizon opportunity thesis for SciTec itself. Why now: No current catalyst is established because the reviewed sources retains no company-specific evidence after the 90-day filter. Caveats: Phase-2 rationale references, but no or retained summary is available in the reviewed sources. Support level is provisional single-article context. No direct company-specific positive or negative evidence remain after recent evidence window. |
| 365 | SEALSQ Corp lowweak | Opp 1 Risk 2 | Thesis: Reviewed evidence membership rationale says SEALSQ is directly involved with WISeSat in a planned 100-satellite QSOC constellation and post-quantum satellite launches, which could indicate long-horizon strategic relevance, but no usable direct positive evidence or article survive the 90-day served evidence set in these reviewed sources. Why now: Why now is weak because the 90-day reviewed sources contain no available evidence after recent evidence window for SEALSQ, despite article history existing in the broader corpus. Caveats: No direct positive or negative evidence available after recent evidence window. Membership rationale references article IDs and, but the reviewed sources provide no for them, so they cannot be cited as factual support under the the evidence standard. |
| 366 | SEALSQ Corp lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence context links SEALSQ to post-quantum payload development with WISeSat, but there is no retained direct positive evidence inside the 90-day recent evidence window to support a 1 year+ opportunity thesis. Why now: There is no usable current evidence because articles after recent evidence window = 0 and evidence after recent evidence window = 0 following the March 29, 2026 cutoff. Caveats: No surviving recent evidence window-qualified evidence. Space relevance in reviewed sources rationale does not establish direction. |
| 367 | SES S.A. lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources membership rationale places SES in satellite communications and infrastructure contexts, but there are no available within the recent evidence window evidence or article details to support a directional opportunity thesis for this screen. Why now: Why-now is weak because no reviewed evidence are available after recent evidence window, so recency and catalysts cannot be assessed from the reviewed sources. Caveats: Membership rationale references and, but no corresponding available article summaries or evidence are provided. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Cohort membership does not establish opportunity. |
| 368 | Sidus Space Inc. lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources' membership rationale references payload and agreement expansion activity, but no retained within the recent evidence window direct evidence or article summaries are available here to support a positive investment-style thesis. Why now: There is no retained dated company evidence after the 90-day recent evidence window; timing support for a 1 year+ thesis is absent in the reviewed sources. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. The membership rationale mentions article IDs, and, but no or retained evidence content are provided in these reviewed sources. |
| 369 | SkyFi lowweak | Opp 1 Risk 1 | Thesis: No direct positive evidence is available, so there is no supportable upside thesis from these reviewed sources alone. Why now: Membership rationale says SkyFi was mentioned as a commercial access partner for Vantor's satellite imagery constellation in article, but this is only contextual and no or direct evidence are provided. Caveats: Partner context is weaker than direct company evidence. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources. |
| 370 | Skyfora lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only says Skyfora appears in a funding roundup with a €6.5M raise, but no retained direct evidence or article summaries are provided after the 90-day recent evidence window, so there is not enough evidence to support a positive 1 year+ thesis. Why now: No within the recent evidence window company-specific catalyst is provided. The reviewed sources reports zero reviewed evidence after the 90-day cutoff for Skyfora, so recency is insufficiently grounded. Caveats: Phase-2 rationale references a €6.5M raise tied to: but no representative article, or retained evidence row is provided in these reviewed sources, so it cannot be used as direct scored evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership review status is not directional proof. |
| 371 | Solestial Inc. lowweak | Opp 1 Risk 1 | Thesis: No positive thesis is supportable from these reviewed sources because no retained direct positive evidence is provided inside the recent evidence window. Why now: No current catalyst can be established from the reviewed sources; the company has zero evidence after recent evidence window. Caveats: Phase-2 rationale says York Space Systems acquired Solestial and cites: but no article summary or is provided here, so it cannot be used as cited factual support. Coverage debug shows 4 articles considered and 0 article IDs after recent evidence window. Absence of evidence is not positive or negative proof. |
| 372 | Solstar Space Company lowweak | Opp 1 Risk 1 | Thesis: The membership rationale says Solstar's Deke Space Communicator operated in orbit and achieved TRL 9 with two-way data transmission and onboard Wi-Fi, which could imply commercialization potential, but no direct positive evidence or article summaries are available for scoring in these reviewed sources. Why now: The reviewed sources contain no reviewed evidence after recent evidence window for this company, preventing a recency-based 1 year+ ranking judgment beyond watchlist status. Caveats: Membership rationale references article, but no direct summary or evidence row is available here for citation. Coverage debug shows zero available evidence after recent evidence window. Private-company status is not itself positive or negative. |
| 373 | Space Systems/Loral, LLC (SSL) lowweak | Opp 1 Risk 1 | Thesis: SSL is referenced in membership rationale as appearing among key players in an optical satellite market report, but that is only article-level industry context and no direct within the recent evidence window evidence is available. Why now: No current catalyst can be established because coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window. The rationale cites: without a in these reviewed sources. Caveats: Only industry-report context is referenced in membership rationale. No direct event/fact evidence survived the recent evidence window. |
| 374 | Space42 lowweak | Opp 1 Risk 1 | Thesis: Space42 is described in membership rationale as operating a SAR Earth observation constellation with satellites entering full operation, but the reviewed sources retains no direct evidence or article summaries within the recent evidence window to support a current opportunity ranking. Why now: Why now is weak because coverage data shows no articles after recent evidence window and no evidence after recent evidence window. Caveats: Membership rationale references article IDs but no are provided, so they cannot be used as cited factual support here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. |
| 375 | SpaceLocker lowweak | Opp 1 Risk 1 | Thesis: There is not enough retained evidence in the recent evidence window to underwrite a durable opportunity case, despite membership rationale describing a first shared satellite mission. Why now: No article-level or event-level evidence were retained after the March 29, 2026 recent evidence window cutoff; recency for the membership rationale is therefore unusable for ranking. Caveats: Membership rationale references article, but no representative article summary or retained evidence row is included. Single-article universe with zero retained rows limits confidence materially. |
| 376 | SpaceLogistics (Northrop Grumman) lowweak | Opp 1 Risk 2 | Thesis: The reviewed sources contain a descriptive article saying SpaceLogistics provides cooperative in-orbit satellite servicing using commercial servicing vehicles, which supports strategic relevance as a business category, but the only cited article is dated March 4, 2025 and was dropped by the 90-day recent evidence window. Why now: Why now is weak because the only cited article, March 4, 2025), falls outside the 90-day recent evidence window and was dropped; recency therefore does not support an active thesis here. Caveats: No evidence were kept after recent evidence filtering. Cannot rely on dropped 2025 evidence for a current ranking. Company-category relevance is not sufficient for a directional opportunity thesis. |
| 377 | Spaceworks lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only says Momentus's fully booked Vigoride 8 mission will carry a Spaceworks COSMIC payload, which indicates some space-payload involvement but does not establish a durable company-specific opportunity thesis for Spaceworks. Why now: No within the recent evidence window retained catalyst is available. The phase-2 rationale references, but no, timestamp, or retained summary is included. Caveats: Support is provisional single-article context only. No retained direct evidence after recent evidence window. Payload mention does not prove company-level commercial traction. |
| 378 | Spacium lowweak | Opp 1 Risk 2 | Thesis: Spacium has a potentially attractive refueling/logistics angle, and an older article says it raised an oversubscribed $6.3 million seed round, but that dated evidence is outside the 90-day recent evidence window and therefore cannot support a current-ranked opportunity thesis. Why now: The only cited article is dated January 23, 2025, and the reviewed sources explicitly shows it was dropped by the 90-day recent evidence window cutoff of March 29, 2026. Caveats: All dated evidence was excluded by recent evidence window. Do not use out-of-window article as current recency proof. |
| 379 | SSC Space lowweak | Opp 1 Risk 1 | Thesis: No positive thesis is supportable from these reviewed sources because no direct positive evidence remains after recent evidence filtering. Why now: There is no retained within the recent evidence window evidence for a current catalyst. Caveats: Phase-2 rationale mentions a sponsored article and a partnership supporting Firefly's Blue Ghost lunar lander antennas, citing, but no or article summary is provided in these reviewed sources. Coverage debug shows 3 articles considered and 0 after recent evidence window. Sponsored-article context would be weaker than direct event/fact evidence even if fully provided. |
| 380 | ST Engineering lowweak | Opp 1 Risk 1 | Thesis: Only weak, supporting article context suggests ST Engineering had involvement in SAR and AI geospatial analytics for satellite ocean surveillance, but the reviewed sources contain no direct positive evidence after the 90-day recent evidence window and no article to substantiate a durable 1 year+ opportunity thesis (: not provided in reviewed sources). Why now: There is no usable dated direct evidence inside the recent evidence window; the reviewed sources explicitly shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, so recency-based timing is unsupported. Caveats: No direct evidence remained after the recent evidence filter. Representative articles are empty, so no is available in the reviewed sources. Membership rationale is weaker than company-specific event evidence. |
Risk view
Showing rows 141-160 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 141 | Cosmoserve Space lowweak | Opp 2 Risk 2 | Thesis: Risk is mainly early-stage execution uncertainty and limited evidence depth: only two articles considered and zero available evidence after recent evidence window. Why now: Why now is weak because the reviewed sources does not establish current demo timing or funding status with direct evidence after recent evidence window. Caveats: Private company with thin visible evidence in these reviewed sources. Mission/demo status cannot be validated from available evidence. |
| 142 | D-Orbit lowweak | Opp 3 Risk 2 | Thesis: The main risk is evidentiary: the reviewed sources lack strong recent company-specific event/facts within the recent evidence window, limiting confidence on current execution state. Why now: Why-now is weak because retained evidence after recent evidence window is mostly undated context; one cited article is from February 14, 2026 and therefore outside the 90-day evidence window, while the remaining available context is undated. Evidence
Caveats: Reviewed evidence membership rationale mentions a €119 million ESA contract, but no citeable retained row for that contract is included here. Series D funding mention is in a February 14, 2026 article outside the 90-day recent evidence window. Undated context is not recency proof. |
| 143 | Dhruva Space lowweak | Opp 4 Risk 2 | Thesis: The risk is that none of the cited grant or partnership evidence is actually available into the kept post-recent evidence window evidence set, so durability, funding size, execution status, and commercial conversion remain unverified in the reviewed sources. Why now: The reviewed sources references: and: in the membership rationale, suggesting relatively recent strategic developments, but the coverage report still shows zero evidence after recent evidence window, so timing confidence is limited. Caveats: Positive thesis relies on membership rationale, not available direct evidence. Partnership evidence cannot be expanded through relation propagation beyond what is explicitly stated. |
| 144 | EarthDaily lowweak | Opp 1 Risk 2 | Thesis: Main risk in these reviewed sources is evidence absence rather than a documented business setback. With no available within the recent evidence window direct positive or negative evidence, visibility into current traction, financing, or execution is poor. Why now: Why now is weak because the reviewed sources show zero evidence kept within the 90-day recent evidence window for ranking, making recency and business-state assessment uncertain. Caveats: Phase-2 membership rationale references: but no or available evidence row is provided in these reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Cannot treat cohort membership as thesis attractiveness. |
| 145 | ElevationSpace mediummedium | Opp 6 Risk 2 | Thesis: Risk is mostly normal scale-up and execution risk from pursuing ambitious transportation and recovery-platform goals; the reviewed sources does not provide direct negative evidence such as delays, litigation, or financing stress. Why now: The catalyst is recent and dated: the financing article is timestamped June 19, 2026, which is inside the 90-day recent evidence window and recent enough to matter for a 1 year+ business-building horizon. Evidence
Caveats: Support is still supporting article context rather than direct positive events. Only one article is available, limiting corroboration. |
| 146 | Eta Space lowweak | Opp 4 Risk 2 | Thesis: The reviewed sources does not provide material negative evidence, but development and mission-execution risk remain implicit because the thesis rests on a demonstration mission rather than proven commercial scale. Why now: The membership rationale specifically points to the LOXSAT mission demonstration as the current relevance driver, citing article: but the reviewed sources does not include the article or more detailed dated evidence fields. Caveats: Underlying article is not provided in the reviewed sources. Score is based on membership rationale summary rather than available direct evidence. Single-mission validation is weaker than broad commercial traction. |
| 147 | Exquadrum, Inc. lowweak | Opp 2 Risk 2 | Thesis: The evidence is minimal and mostly acquisition context rather than direct company-specific operating evidence. Without retained post-recent evidence window detail, there is no basis for a stronger opportunity or risk call, and ownership/status changes may have already altered standalone operating exposure. Why now: No retained evidence establishes current milestone timing or post-acquisition integration progress, so there is no strong why-now supported in these reviewed sources. Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Acquisition context is weaker than direct operating evidence. |
| 148 | Fergani Space lowweak | Opp 2 Risk 2 | Thesis: The main risk is evidentiary uncertainty: there is no available direct adverse evidence, but there is also no post-recent evidence window operating, financing, customer, or execution evidence to confirm momentum. Why now: There is no credible 'why now' catalyst in the reviewed sources because articles after recent evidence window and evidence after recent evidence window are both zero for this company. The only cited support is older or excluded from the active evidence set: article, referenced in the membership rationale, was outside the kept recent evidence window according to the company coverage report. Caveats: No evidence were available after recent evidence filtering. No representative articles or additional_company_articles were provided. Membership rationale is weaker than direct event/fact evidence. |
| 149 | Firefly Aerospace lowweak | Opp 4 Risk 2 | Thesis: The evidence is limited to one recent article-level source and does not provide strong company-specific downside evidence, so risk stays low but uncertainty remains high. Why now: A dated May 26, 2026 article puts a fresh NASA program win into the current evidence window, which can matter over a 1 year+ horizon even if revenue realization is later. Evidence
Caveats: Only one within the recent evidence window article is available. Evidence is supporting article context rather than stronger extracted direct events. Timing of mission realization is long-dated relative to the evidence window. |
| 150 | GalaxEye Space lowweak | Opp 2 Risk 2 | Thesis: Risk is mainly lack of current evidentiary confirmation rather than documented business trouble. Why now: There is no within the recent evidence window evidence available in these reviewed sources for GalaxEye Space; timing and maturity of current milestones cannot be confirmed from reviewed sources evidence. Caveats: Membership rationale cites article IDs and, but their article content is not provided here for citation. Evidence recent evidence review shows 0 kept rows. This entity may overlap with GalaxEye Space Solutions Private Ltd, but the output contract requires scoring both separately. |
| 151 | GalaxEye Space Solutions Private Ltd lowweak | Opp 1 Risk 2 | Thesis: Risk is mainly evidence uncertainty rather than documented adverse developments, because no direct negative evidence or current operating milestones were available after the recent evidence filter. Why now: There is no within the recent evidence window evidence available for this entity in the reviewed sources; recency of any business progress is uncertain. Caveats: Evidence recent evidence review shows 0 kept rows after the 90-day cutoff for this entity. Membership rationale references article IDs, and: but no article summaries or direct evidence are included in these reviewed sources for citation-level use. Scores are constrained by absence of directional evidence, not by a proven negative business outcome. |
| 152 | GalaxySpace lowweak | Opp 3 Risk 2 | Thesis: No material adverse evidence is present, but the evidence is too limited and research-oriented to reduce uncertainty materially. Why now: The reviewed sources references article: for the research institute setup, yet does not provide the article or direct event details to assess timing or commercial conversion. Caveats: Only one article is considered and no representative article object is provided. Research institute formation is weaker than product, contract, or financing milestones. Commercial impact timing is unclear. |
| 153 | GALVANY lowweak | Opp 2 Risk 2 | Thesis: The same evidence creates moderate execution/classification risk: the company may have financing momentum, but the reviewed sources does not establish that it fits the target cohort or that the funding translates into durable business opportunity. No direct adverse event is available. Why now: The only possible timing angle is the referenced seed raise in the membership rationale, but no -backed available evidence remains after the recent evidence filter, so recency and impact cannot be validated for scoring. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Funding context does not prove target-cohort fit. |
| 154 | Gate Space lowweak | Opp 3 Risk 2 | Thesis: Risk is modest because the evidence base is only one undated, supporting article context with no direct company events beyond funding context, making current status and durability uncertain Why now: For a 1 year+ horizon, funding can matter, but recency is uncertain because the article is explicitly undated and the reviewed sources say undated external evidence is relevance context rather than recency proof Evidence
Caveats: The evidence is weak context and supporting article context, not direct structured company event/fact evidence. The article is undated; the reviewed sources explicitly says recency-sensitive claims should be treated cautiously. Same-article repeated rows are not independent confirmation. |
| 155 | General Atomics mediummedium | Opp 6 Risk 2 | Thesis: The main risk is evidentiary rather than operational: the reviewed sources contain no direct negative evidence, but also no company-specific contract value, backlog, execution milestone, or follow-on detail. The Andromeda item is supporting article context and same-article repeats are not independent confirmation, so the opportunity could be overstated if General Atomics' role is small or non-recurring., April 8, 2026 Why now: The catalyst is recent within the reviewed sources recent evidence window: the is April 8, 2026, and it describes Space Force awarding Andromeda contracts, a potentially durable procurement cycle relevant to a 1 year+ horizon., April 8, 2026 Evidence
Caveats: This is supporting article context/weak context, not a direct company event row. Same-article repeated rows in the reviewed sources are not independent confirmation. |
| 156 | GEOST lowweak | Opp 2 Risk 2 | Thesis: The main risk is lack of current standalone visibility: because evidence appears tied to acquired-business context and no retained rows are included, current operating status, ownership implications, and commercial significance cannot be established from these reviewed sources. Why now: There is no retained within the recent evidence window evidence. Any thesis would rely on older context referenced in the membership rationale, which is insufficient for a stronger rank. Caveats: Reviewed evidence references acquired-business context rather than current standalone operations. No representative articles or retained evidence are included. Low scores reflect missing timely evidence, not a directional call on the business. |
| 157 | GHGSat lowweak | Opp 2 Risk 2 | Thesis: Risk appears limited based on the reviewed sources only because there is no adverse evidence, but confidence is low since there is also no direct traction, contract, funding, or milestone evidence available. Why now: The reviewed sources offers no recent evidence window-supported event timing for a why-now view. Caveats: The membership rationale says GHGSat is the world's leading commercial greenhouse gas monitoring satellite company, but the supporting article content is not available here for ranking use. Absence of negative evidence is not positive evidence. |
| 158 | Globalstar lowweak | Opp 2 Risk 2 | Thesis: There is no direct adverse evidence in the reviewed sources; risk is limited to uncertainty from missing current evidence rather than any documented deterioration. Why now: No within the recent evidence window evidence were available for Globalstar in these reviewed sources, so there is no current catalyst basis to elevate either opportunity or risk. Caveats: Evidence recent evidence review shows 0 kept rows after the 90-day cutoff. Membership rationale cites article IDs, and: but those article contents are not provided here for direct factual citation. Public company status does not improve ranking without directional evidence. |
| 159 | Guodian Gaoke lowweak | Opp 5 Risk 2 | Thesis: No direct negative evidence is shown; key risk is uncertainty around monetization, expansion beyond Phase I, and lack of corroborating direct evidence in the reviewed sources. Why now: The why-now would be the reported trial license and completed Phase I constellation, but the reviewed sources does not provide the underlying article summary or date-specific evidence for stronger timing confidence. Caveats: Phase2 membership rationale references: but no summary/evidence row is available to cite directly. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Score exceeds Beijing Guodian High-Tech slightly because rationale mentions both licensing and constellation completion. |
| 160 | Guoxing Aerospace Technology lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources also says the company-specific operating category is not clearly established from the provided evidence alone. That uncertainty, plus the lack of retained direct evidence, limits confidence in any positive thesis. Why now: Space-based AI computing could be strategically relevant over 1 year+, but the reviewed sources provide no retained dated evidence to confirm partnership scope, timing, or commercial milestones. Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Partnership mention alone is insufficient to prove durable company impact. |